IAD: Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders

Sponsor
Federico II University (Other)
Overall Status
Completed
CT.gov ID
NCT05365932
Collaborator
(none)
10
1
1
12.4
0.8

Study Details

Study Description

Brief Summary

Background: An innovative, non-invasive, and reversible Intra Auricular Device (IAD) has recently been introduced to treat temporomandibular muscle and joint disorders.Aim: To evaluate the effects of the IAD on pain, psychosocial domain and Pressure Pain Threshold (PPT) of masticatory muscles in patients with TMD pain. Methods: Ten subjects with TMD pain and with pain intensity higher than 30 mm on a VAS scale were included in the study. Patients received the IAD and counselling. Assessments included questionnaires of the DC/TMD Axis II questionnaires (Characteristic Pain Index, Interference, Jaw Functional Limitation Scale, Patient Health Questionnaire 9, Patient Health Questionnaire 15, Generalized Anxiety Disorder scale, Oral Behavior Checklist and Oral Health Impact Profile-22, Axis I clinical examination and PPTs at baseline (T0), after one month (T1), three months (T2) and six months (T3) from the first use of the device. PPTs were measured at anterior temporalis muscles, masseter muscles and right thenar as a control site.The Shapiro-Wilk test was used for the normal distribution of data. The difference among the longitudinal timepoints for variable was analysed with ANOVA. Statistical significance was accepted at p < 0.05.

Condition or Disease Intervention/Treatment Phase
  • Device: Intra auricular device (IAD)
N/A

Detailed Description

The goal of ths study is to evaluate the effects of a new intra auricular device, the IAD, on pain, psychosocial domain and Pressure Pain Threshold (PPT) of facial muscles in patients with diagnosis of TMD pain according to the Diagnostic Criteria of Temporomandibular Disorders

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Longitudinal Study for the Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders
Actual Study Start Date :
Nov 29, 2018
Actual Primary Completion Date :
May 8, 2019
Actual Study Completion Date :
Dec 10, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: TMD Pain group

Arm included patients with TMD Pain intensity >3 on a VAS scale and with diagnosis of myofascial pain, either alone or in combination with arthralgia, headache attributable to TMD or with disc displacement with reduction. Participants had to be 18 years of age or older. All subjects had to wear the device for 6 months and it should not be used for more than 23 hours in a 24-hour period

Device: Intra auricular device (IAD)
The Intra Auricular Device (IADs) are a pair of inconspicuous, custom fit auricular prosthetic devices.The ear inserts are manufactured using computer-aided design/computer-aided manufacturing (CAD/CAM) technology and are made from a liquid, photo-reactive acrylate (EShell 300), used in hearing aid shells and otoplastics for the last 10 years. They are designed to be placed into the outer third of the ear canals, and they have a small retraction post used to facilitate removal . A red or blue dot, respectively, indicates the right and the left side. The device do not interfere with hearing or speech

Outcome Measures

Primary Outcome Measures

  1. Change of Pain (evaluated with Characteristic pain intensity scale) [Six months from the first use of the device]

    This questionnaire is a valid instrument assessing pain intensity, numbers of days with interference and pain-related disability in the last month. The characteristic pain intensity score, which ranges from 0-100, is calculated as the mean intensity ratings for reported current, worst, and average pain

  2. Change of Pain evaluated with instrumental exam( Pain Pressure Threshold) [Six months from the first use of the device]

    Pain Pressure Threshold were assessed by a single examiner at the anterior temporalis and masseter muscles (respectively TdxM; TsxM; MdxM; MsxM). An additional measurement was performed at the right thenar muscle (TenM) selected as a control muscular site.

  3. Psychosocial domain positive change [Six months from the first use of the device]

    Evaluation of psychosocial positive change through psychosocial questionnaires.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age >18

  • TMD-pain diagnosed according to the DC/TMD (myalgia, myofascial pain, arthralgia, headache attributable to TMD)

  • disc displacement with reduction

Exclusion Criteria:
  • disc displacement without reduction

  • intermittent locking

  • degenerative TMJ disorder

  • craniofacial anomaly

  • history of prior TMJ

  • orthognathic surgery

  • recent (within the past six months) trauma to the face or jaw

  • current, active orthodontic treatment

  • severe mental health disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Donnarumma Valeria Afragola Italy 80021

Sponsors and Collaborators

  • Federico II University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Valeria Donnarumma, Principal Investigator, Federico II University
ClinicalTrials.gov Identifier:
NCT05365932
Other Study ID Numbers:
  • 303/18
First Posted:
May 9, 2022
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Valeria Donnarumma, Principal Investigator, Federico II University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2022